Amyotrophic lateral sclerosis: Prognostic indicators of survival

References

• Munsat T. L., Andres P. I., Skerry P. L. The use of quantitative techniques to define amyotrophic lateral sclerosis. Quantification of Neurologic Deficit, T. L Munsat. Butterworth‐Heinemann, Boston, Mass. 1989; 129–42
   Google Scholar
• Christensen P. B., Hojer‐Pedersen E., Jensen N. B. Survival of patients with amyotrophic lateral sclerosis in two Danish counties. Neurology 1990; 40: 600–4
   PubMed Web of Science ®Google Scholar
• Norris F., Shepherd R., Denys E., Mukai E., Elias L., Holden D., et al. Onset, natural history and outcome in idiopathic adult motor neuron disease. J Neurol Sci 1993; 118: 48–55
   PubMed Web of Science ®Google Scholar
• Magnus T., Beck M., Giess R., Puls I., Naumann M., Toyka K. V. Disease progression in amyotrophic lateral sclerosis: predictors of survival. Muscle Nerve 2002; 25: 709–14
   PubMed Web of Science ®Google Scholar
• Tysnes O. B., Vollset S. E., Aarli J. A. Epidemiology of amyotrophic lateral sclerosis in Hordaland county, western Norway. Acta Neurol Scand 1991; 83: 280–5
   PubMed Web of Science ®Google Scholar
• Chancellor A. M., Warlow C. P. Adult onset motor neuron disease: worldwide mortality, incidence and distribution since 1950. J Neurol Neurosurg Psychiatry 1992; 55: 1106–15
   PubMed Web of Science ®Google Scholar
• Eisen A., Schulzer M., MacNeil M., Pant B., Mak E. Duration of amyotrophic lateral sclerosis is age‐dependent. Muscle Nerve 1993; 16: 27–32
   PubMed Web of Science ®Google Scholar
• Haverkamp L. J., Appel V., Appel S. H. Natural history of amyotrophic lateral sclerosis in a database population. Validation of a scoring system and a model for survival prediction. Brain 1995; 118: 707–19
   PubMed Web of Science ®Google Scholar
• Ringel S. P., Murphy J. R., Alderson M. K., Bryan W., England J. D., Miller R. G., et al. The natural history of amyotrophic lateral sclerosis. Neurology 1993; 43: 1316–22
   PubMed Web of Science ®Google Scholar
• Gubbay S. S., Kahana E., Zilber N., Cooper G., Pintov S., Leibowitz Y. Amyotrophic lateral sclerosis: a study of its presentation and prognosis. J Neurol 1985; 232: 295–300
   PubMed Web of Science ®Google Scholar
• Preux P. M., Couratier P., Boutros‐Toni F., Salle J. Y., Tabaraud F., Bernet‐Bernady P., et al. Survival prediction in sporadic amyotrophic lateral sclerosis. Age and clinical form at onset are independent risk factors. Neuroepidemiology 1996; 15: 153–60
   PubMed Web of Science ®Google Scholar
• Traynor B. J., Codd M. B., Corr B., Forde C., Frost E., Hardiman O. Amyotrophic lateral sclerosis mimic syndromes: a population‐based study. Arch Neurol 2000; 57: 109–13
   PubMed Web of Science ®Google Scholar
• Desport J. C., Preux P. M., Truong T. C., Vallat J. M., Sautereau D., Couratier P. Nutritional status is a prognostic factor for survival in ALS patients. Neurology 1999; 53: 1059–63
   PubMed Web of Science ®Google Scholar
• Kasarskis E. J., Berryman S., Vanderleest J. G., Schneider A. R., McClain C. J. Nutritional status of patients with amyotrophic lateral sclerosis: relation to the proximity of death. Am J Clin Nutr 1996; 63: 130–7
   PubMed Web of Science ®Google Scholar
• Del Aguila M. A., Longstreth W. T., Jr., McGuire V., Koepsell T. D., van Belle G. Prognosis in amyotrophic lateral sclerosis: a population‐based study. Neurology 2003; 60: 813–9
   PubMed Web of Science ®Google Scholar
• Turner M. R., Parton M. J., Shaw C. E., Leigh P. N., Al‐Chalabi A. Prolonged survival in motor neuron disease: a descriptive study of the King's database 1990–2002. J Neurol Neurosurg Psychiatry 2003; 74: 995–7
   PubMed Web of Science ®Google Scholar
• Appel V., Stewart S. S., Smith G., Appel S. H. A rating scale for amyotrophic lateral sclerosis: description and preliminary experience. Ann Neurol 1987; 22: 328–33
   PubMed Web of Science ®Google Scholar
• Bradley W. G., Anderson F., Bromberg M., Gutmann L., Harati Y., Ross M., et al. Current management of ALS: comparison of the ALS CARE Database and the AAN Practice Parameter. Neurology 2001; 57: 500–4
   PubMed Web of Science ®Google Scholar
• Jablecki C. K., Berry C., Leach J. Survival prediction in amyotrophic lateral sclerosis. Muscle Nerve 1989; 12: 833–41
   PubMed Web of Science ®Google Scholar
• Armon C., Moses D. Linear estimates of rates of disease progression as predictors of survival in patients with ALS entering clinical trials. J Neurol Sci 1998; 160((Suppl))S37–41
   Google Scholar
• Armon C., Graves M. C., Moses D., Forte D. K., Sepulveda L., Darby S. M., et al. Linear estimates of disease progression predict survival in patients with amyotrophic lateral sclerosis. Muscle Nerve 2000; 23: 874–82
   PubMed Web of Science ®Google Scholar
• Stambler N., Charatan M., Cedarbaum J. M. Prognostic indicators of survival in ALS. ALS CNTF Treatment Study Group. Neurology 1998; 50: 66–72
   PubMed Web of Science ®Google Scholar
• Munsat T. L., Hollander D., Andres P., Finison L. Clinical trials in ALS: measurement and natural history. Adv Neurol 1991; 56: 515–9
   PubMedGoogle Scholar
• Mandrioli J., Faglioni P., Merelli E., Sola P. The epidemiology of ALS in Modena, Italy. Neurology 2003; 60: 683–9
   PubMed Web of Science ®Google Scholar
• World Federation of Neurology Research Group on Motor Neuron Diseases, El Escorial revised criteria for the diagnosis of amyotrophic lateral sclerosis. World Federation of Neurology, Amyotrophic Lateral Sclerosis (online). Available at www.wfnals.org/Articles/elescorial1998.htm; accessed April 2–4, 1998.
   Google Scholar
• Kaplan E. I., Meier P. Non‐parametric estimation from incomplete observations. J Am Stat Assoc 1958; 53: 457–81
   Web of Science ®Google Scholar
• Marubini E., Valsecchi M. G., Eds. Analysing survival data from clinical trials and observational studies. Wiley, New York 1995
   Google Scholar
• Feinstein A. R., Ed. Clinical epidemiology. Saunders, London 1985
   Google Scholar
• Grizzle J. E., Starmer C. F., Koch G. G. Analysis of categorical data by linear models. Biometrics 1969; 25: 489–504
   PubMed Web of Science ®Google Scholar
• Koch G. G., Johnson W. D., Tolley H. D. A linear model approach to the analysis of survival and extent of disease in multidimensional contingency tables. J Am Stat Assoc 1972; 67: 783–96
   Web of Science ®Google Scholar
• StatXact 5 [computer program]. Cytel Software Corporation, Cambridge, Massachusetts 2001
   Google Scholar
• Cox D. R. Regression models and life‐tables (with discussion). Journal of the Royal Statistical Society, B 1972; 34: 187–220
   Web of Science ®Google Scholar
• EGRET [computer program]. Cytel Software Corporation, Cambridge, Massachusetts 2001
   Google Scholar
• Regione Emilia Romagna, La regione in cifre (online). Available at www. regione.emilia‐romagna.it/statistica; accessed February, 2006.
   Google Scholar
• Dietrich‐Neto F., Callegaro D., Dias‐Tosta E., Silva H. A., Ferraz M. E., Lima J. M., et al. Amyotrophic lateral sclerosis in Brazil: 1998 national survey. Arq Neuropsiquiatr 2000; 58: 607–15
   PubMed Web of Science ®Google Scholar
• Briani C., Marcon M., Dam M., Beghi E., Pegoraro E., Angelini C. Motor neuron disease in the Padua district of Italy: an epidemiological study. Neuroepidemiology 1996; 15: 173–9
   PubMed Web of Science ®Google Scholar
• Bettoni L., Bazzani M., Bortone E., Dascola I., Pisani E., Mancia D. Steadiness of amyotrophic lateral sclerosis in the province of Parma, Italy, 1960–1990. Acta Neurol Scand 1994; 90: 276–80
   PubMed Web of Science ®Google Scholar
• Lopez‐Vega J. M., Calleja J., Combarros O., Polo J. M., Berciano J. Motor neuron disease in Cantabria. Acta Neurol Scand 1988; 77: 1–5
   PubMed Web of Science ®Google Scholar
• De Domenico P., Malara C. E., Marabello L., Puglisi R. M., Meneghini F., Serra S., et al. Amyotrophic lateral sclerosis: an epidemiological study in the province of Messina, Italy, 1976–1985. Neuroepidemiology 1988; 7: 152–8
   PubMed Web of Science ®Google Scholar
• Giagheddu M., Mascia V., Cannas A., Pirastru M. I., Sanna F., Rachele M. G., et al. Amyotrophic lateral sclerosis in Sardinia, Italy: an epidemiological study. Acta Neurol Scand 1993; 87: 446–54
   PubMed Web of Science ®Google Scholar
• Sorenson E. J., Stalker A. P., Kurland L. T., Windebank A. J. Amyotrophic lateral sclerosis in Olmsted County, Minnesota, 1925 to 1998. Neurology 2002; 59: 280–2
   PubMed Web of Science ®Google Scholar
• Gross‐Paju K., Oopik M., Luus S. M., Kalbe I., Puksa L., Lepik T., et al. Motor neuron disease in south Estonia. Diagnosis and incidence rate. Acta Neurol Scand 1998; 98: 22–8
   PubMed Web of Science ®Google Scholar
• Kimura F., Fujimura C., Ishida S., Nakajima H., Furutama D., Uehara H., et al. Progression rate of ALSFRS‐R at time of diagnosis predicts survival time in ALS. Neurology 2006; 66: 265–7
   PubMed Web of Science ®Google Scholar
• Longstreth W. T., McGuire V., Koepsell T. D., Wang Y., van Belle G. Risk of amyotrophic lateral sclerosis and history of physical activity: a population based case‐control study. Arch Neurol 1998; 55: 201–6
   PubMedGoogle Scholar
• Kalfakis N., Vassilopoulos D., Voumvourakis C., Ndjeveleka M., Papageorgiou C. Amyotrophic lateral sclerosis in southern Greece: an epidemiological study. Neuroepidemiology 1991; 10: 170–3
   PubMed Web of Science ®Google Scholar
• Chiò A., Mora G., Leone M., Mazzini L., Cocito D., Giordana M. T., et al. Early symptom progression rate is related to ALS outcome: a prospective population‐based study. Neurology 2002; 59: 99–103
   PubMed Web of Science ®Google Scholar
• Gregory S., Siderowf A., Golaszewski A. L., McCluskey L. Gastrostomy insertion in ALS patients with low vital capacity: respiratory support and survival. Neurology 2002; 58: 485–7
   PubMed Web of Science ®Google Scholar
• Mazzini L., Corra T., Zaccala M., Mora G., Del Piano M., Galante M. Percutaneous endoscopic gastrostomy and enteral nutrition in amyotrophic lateral sclerosis. J Neurol 1995; 242: 695–8
   PubMed Web of Science ®Google Scholar
• Kleopa K., Sherman M., Neal B., Romano G. J., Heiman‐Patterson T. Bipap improves survival and rate of pulmonary function decline in patients with ALS. J Neurol Sci 1999; 164: 82–8
   PubMed Web of Science ®Google Scholar
• Lyall R. A., Donaldson N., Fleming T., Wood C., Newsom‐Davis I., Polkey M. I., et al. A prospective study of quality of life in ALS patients treated with non‐invasive ventilation. Neurology 2001; 57: 153–6
   PubMed Web of Science ®Google Scholar
• Louwerse E. S., Visser C. E., Bossuyt P. M., Weverling G. J. Amyotrophic lateral sclerosis: mortality risk during the course of the disease and prognostic factors. The Netherlands ALS Consortium. J Neurol Sci 1997; 152((Suppl 1))S10–7
   PubMed Web of Science ®Google Scholar
• Tysnes O. B., Vollset S. E., Aarli J. A. Prognostic factors and survival in amyotrophic lateral sclerosis. Neuroepidemiology 1994; 13: 226–35
   PubMed Web of Science ®Google Scholar
• Calne D. B., Eisen A. Latent neuroabiotrophies: a clue to amyotrophic lateral sclerosis. Amyotrophic Lateral Sclerosis: Concept in Pathogenesis and Etiology, A. J Hudson. University of Toronto Press, Toronto 1990; 296–316
   Google Scholar
• Forbes R. B., Colville S., Swingler R. J., Scottish ALS/MND Register. The epidemiology of amyotrophic lateral sclerosis (ALS/MND) in people aged 80 years or over. Age Ageing 2004; 33: 131–4
   PubMed Web of Science ®Google Scholar
• Brooks B. R. What are the implications of early diagnosis? Maintaining optimal health as long as possible. Neurology 1999; 53((Suppl))S43–5
   Google Scholar
• McDonald E., Wiedenfeld S. A., Hillel A., Carpenter C. L., Walter R. A. Survival in amyotrophic lateral sclerosis: the role of psychological factors. Arch Neurol 1994; 51: 17–23
   PubMed Web of Science ®Google Scholar
• Traynor B. J., Alexander M., Corr B., Frost E., Hardiman O. Effect of a multidisciplinary amyotrophic lateral sclerosis (ALS) clinic on ALS survival: a population based study, 1996–2000. J Neurol Neurosurg Psychiatry 2003; 74: 1258–61
   PubMed Web of Science ®Google Scholar
• Forbes R. B., Colville S., Cran G. W., Swingler R. J. Unexpected decline in survival from amyotrophic lateral sclerosis/motor neuron disease. J Neurol Neurosurg Psychiatry 2004; 75: 1753–5
   PubMed Web of Science ®Google Scholar
• Albert S. M., Murphy P. L., Del Bene M. L., Rowland L. P. A prospective study of preferences and actual treatment choices in ALS. Neurology 1999; 53: 278–83
   PubMed Web of Science ®Google Scholar